Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What concerns me is not the BOD mistakes its the Reverse Split they are planning

You forgot the rest of the quote.

<The board is not anxious to move toward a reverse split until it believes that:

1. The company has a reliable, long term opportunity for growth of (less volatile) revenues, profits and shareholder value and,

2. A reverse split will not risk a reduction of the market capitalization of the company.

Again, no definitive timeline has been outlined for considering these actions, but I believe that the shareholders understand the companys objectives, and perspectives, with respect to these possible actions. >

Was there a reason for excluding this part? Opty

Share
New Message
Please login to post a reply